World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
56
Citations
10605
World Ranking
4537
National Ranking
2048

Overview

Nabeel Nabulsi is affiliated with Yale University in the United States and is engaged in research primarily within medicine and neuroscience. Their work spans multiple subfields including cellular and molecular neuroscience, radiology, nuclear medicine and imaging, cognitive neuroscience, physiology, and molecular biology.

Their research focuses on areas such as neuroscience and neuropharmacology, functional brain connectivity, Alzheimer's disease research and treatments, medical imaging techniques, neuroinflammation and neurodegeneration mechanisms, epilepsy research, and the role of tryptophan in brain disorders.

Nabulsi has published extensively in frequent venues, contributing to journals including:

  • Biological Psychiatry
  • Alzheimer's & Dementia
  • Journal of Nuclear Medicine
  • American Journal of Geriatric Psychiatry
  • European Journal of Nuclear Medicine and Molecular Imaging

Their recent publications include:

  • In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET, 2020, Alzheimer's & Dementia
  • Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging, 2020, Annals of Neurology
  • Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [11C]UCB-J, 2022, Alzheimer's & Dementia
  • First-in-Human Evaluation of 18F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A, 2020, Journal of Nuclear Medicine
  • Association of Aβ deposition and regional synaptic density in early Alzheimer's disease: a PET imaging study with [11C]UCB-J, 2021, Alzheimer's Research & Therapy

Among frequent co-authors collaborating with Nabulsi are:

  • Richard E. Carson
  • Yiyun Huang
  • Mika Naganawa
  • David Matuskey
  • Jim Ropchan

Best Publications

  • Imaging synaptic density in the living human brain

    Sjoerd J. Finnema;Nabeel B. Nabulsi;Tore Eid;Kamil Detyniecki

  • Lower synaptic density is associated with depression severity and network alterations.

    Sophie E. Holmes;Dustin Scheinost;Sjoerd J. Finnema;Mika Naganawa

  • Deficits in Prefrontal Cortical and Extrastriatal Dopamine Release in Schizophrenia: A Positron Emission Tomographic Functional Magnetic Resonance Imaging Study

    Mark Slifstein;Mark Slifstein;Elsmarieke van de Giessen;Elsmarieke van de Giessen;Jared Van Snellenberg;Jared Van Snellenberg;Judy L. Thompson;Judy L. Thompson;Judy L. Thompson

  • Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.

    Ming-Kai Chen;Adam P. Mecca;Mika Naganawa;Sjoerd J. Finnema

  • Imaging robust microglial activation after lipopolysaccharide administration in humans with PET

    Christine M. Sandiego;Jean-Dominique Gallezot;Brian Pittman;Nabeel Nabulsi

  • Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain

    Nabeel B. Nabulsi;Joël Mercier;Daniel Holden;Stephane Carré

  • In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET

    Adam P Mecca;Ming-Kai Chen;Ryan S O'Dell;Mika Naganawa

  • Kinetic evaluation and test-retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans.

    Sjoerd J Finnema;Nabeel B Nabulsi;Joël Mercier;Shu-fei Lin

  • Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [11C]UCB‐J

    Unknown

  • Sex Differences in the Brain's Dopamine Signature of Cigarette Smoking

    Kelly P. Cosgrove;Shuo Wang;Su-Jin Kim;Erin McGovern

  • The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: A [11C]PBR28 PET study

    Jonas Hannestad;Nicole DellaGioia;Jean-Dominique Gallezot;Keunpoong Lim

  • PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)‐[11C]O‐methylreboxetine and HRRT

    Yu-Shin Ding;Tarun Singhal;Beata Planeta-Wilson;Jean-Dominique Gallezot

  • Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging.

    David Matuskey;Sule Tinaz;Kyle C. Wilcox;Mika Naganawa

  • Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action.

    Jean‐Marie Nicolas;Jonas Hannestad;Daniel Holden;Sophie Kervyn

  • Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [ 11 C]ABP688 and PET imaging study in depression

    I Esterlis;N DellaGioia;R H Pietrzak;R H Pietrzak;D Matuskey

  • Altered metabotropic glutamate receptor 5 markers in PTSD: In vivo and postmortem evidence

    Sophie E. Holmes;Matthew J. Girgenti;Margaret T. Davis;Robert H. Pietrzak

  • Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO

    Ragy R. Girgis;Ragy R. Girgis;Mark Slifstein;Deepak D’Souza;Yih Lee;Yih Lee

  • The Effect of Early Trauma Exposure on Serotonin Type 1B Receptor Expression Revealed by Reduced Selective Radioligand Binding

    James W. Murrough;Christoph Czermak;Shannan Henry;Nabeel Nabulsi

  • Kinetic Modeling of the Serotonin 5-HT1B Receptor Radioligand [11C]P943 in Humans

    Jean Dominique Gallezot;Nabeel Nabulsi;Alexander Neumeister;Beata Planeta-Wilson

  • PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases.

    Zhengxin Cai;Songye Li;David Matuskey;Nabeel Nabulsi

  • In vivo ketamine-induced changes in [¹¹C]ABP688 binding to metabotropic glutamate receptor subtype 5.

    Christine DeLorenzo;Nicole DellaGioia;Michael Bloch;Gerard Sanacora

Frequent Co-Authors

Mika Naganawa
Mika Naganawa Yale University
Kelly P. Cosgrove
Kelly P. Cosgrove Yale University
Yu-Shin Ding
Yu-Shin Ding New York University
Amy F.T. Arnsten
Amy F.T. Arnsten Yale University
Robert T. Malison
Robert T. Malison Yale University
Robert H. Pietrzak
Robert H. Pietrzak Yale University
Marc N. Potenza
Marc N. Potenza Yale University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Neuroscience, there are several online degree options that can broaden your career prospects in mental health, psychology, and social work. Many students choose to complement or transition from neuroscience studies into related fields, leveraging their scientific background for rewarding careers helping individuals, families, and communities.

If you are passionate about clinical counseling, consider an accredited marriage and family therapy degree online. This path prepares graduates to support clients in a variety of therapeutic settings.

A popular alternative is pursuing an affordable online masters in psychology, which opens doors to advanced practice or doctoral study. Undergraduate candidates can explore a variety of psychology degrees to build foundational knowledge in behavior and cognition—skills highly sought after in neuroscience and related careers.

Those interested in social justice, policy, or community health may find social work a fulfilling path. To learn about flexibility and requirements, find out how long does it take to get a msw online. No matter your route, these related fields offer impactful opportunities and can be pursued conveniently through online study.

Best Scientists Citing Nabeel Nabulsi

Trending Scientists